Answers are grounded in this paper and cite their sources.
Ovarian aging and premature ovarian insufficiency (POI) are associated with reproductive decline and increased risks of selected age-related disorders. Whether the ovary independently transmits inflammatory signals that accelerate dysfunction in distant organs remains incompletely defined. This narrative review critically examines three potential communication routes: senescence-associated secretory phenotype (SASP) factors, extracellular vesicles (EVs), and mitochondrial DNA (mtDNA)-associated innate immune signaling. Experimental studies support local ovarian inflammaging, age-related changes in follicular-fluid EV cargo, and transfer of oocyte-derived cGAMP to adjacent granulosa cells through gap junctions. However, none of these findings alone establishes an ovary-derived circulating mediator causing liver, adipose-tissue, or systemic endothelial disease. We distinguish direct ovarian evidence from data on general senescence, hepatic EV uptake, adipose-liver interactions, and vascular mtDNA sensing. We also critically summarize preclinical research on traditional Chinese medicine targeting ovarian inflammatory pathways, emphasizing the lack of clinical evidence for prevention of distal-organ dysfunction. Priority questions include the source-specific tracking of ovarian EVs, the origin and biological activity of circulating cell-free mtDNA, and potential roles of local immunoglobulins and complement. A tissue-of-origin-resolved research framework is needed before systemic anti-inflammaging therapies, including both pharmaceutical and herbal interventions, can be recommended for women with diminished ovarian reserve or POI.
No takes yet. Share an insight, caveat, or question.
Di et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: